Literature DB >> 31848752

Idiopathic nephrotic syndrome and serum permeability factors: a molecular jigsaw puzzle.

Jean-Jacques Candelier1,2, Hans-Kristian Lorenzo3,4,5.   

Abstract

Nephrotic syndrome is traditionally defined using the triad of edema, hypoalbuminemia, and proteinuria, but this syndrome is very heterogeneous and difficult to clarify. Its idiopathic form (INS) is probably the most harmful and essentially comprises two entities: minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS). We will consider some hypotheses regarding the mechanisms underlying INS: (i) the presence of several glomerular permeability factors in the sera of patients that alter the morphology and function of podocytes leading to proteinuria, (ii) the putative role of immune cells. Thanks to recent data, our understanding of these disorders is evolving towards a more multifactorial origin. In this context, circulating factors may be associated according to sequential kinetic mechanisms or micro-environmental changes that need to be determined. In addition, the resulting proteinuria may trigger more proteinuria enhancing the glomerular destabilization.

Entities:  

Keywords:  Focal segmental glomerulosclerosis; Minimal change disease; Nephrotic syndrome; Permeability factors; Proteinuria

Mesh:

Substances:

Year:  2019        PMID: 31848752     DOI: 10.1007/s00441-019-03147-y

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  6 in total

1.  Circulating miRNAs in extracellular vesicles related to treatment response in patients with idiopathic membranous nephropathy.

Authors:  In O Sun; Yun-Ui Bae; Kyung-Oh Doh; Soon Hyo Kwon; Haekyung Lee; Hyoungnae Kim; Jin Seok Jeon; Hyunjin Noh; Jong-Soo Choi
Journal:  J Transl Med       Date:  2022-05-14       Impact factor: 8.440

2.  Amount and selectivity of proteinuria may predict the treatment response in post-transplant recurrence of focal segmental glomerulosclerosis: a single-center retrospective study.

Authors:  Hideki Ban; Kenichiro Miura; Naoto Kaneko; Yoko Shirai; Tomoo Yabuuchi; Kiyonobu Ishizuka; Hiroko Chikamoto; Yuko Akioka; Satoru Shimizu; Hideki Ishida; Kazunari Tanabe; Motoshi Hattori
Journal:  Pediatr Nephrol       Date:  2021-02-04       Impact factor: 3.714

3.  Persistent Abnormalities of Fatty Acids Profile in Children With Idiopathic Nephrotic Syndrome in Stable Remission.

Authors:  Stefano Turolo; Alberto C Edefonti; William Morello; Marie-Louise Syren; Valentina De Cosmi; Luciana Ghio; Chiara Tamburello; Erika A Demarco; Alfredo Berrettini; Gianantonio Manzoni; Carlo Agostoni; Giovanni Montini
Journal:  Front Pediatr       Date:  2021-01-27       Impact factor: 3.418

Review 4.  Therapeutic trials in adult FSGS: lessons learned and the road forward.

Authors:  An S De Vriese; Jack F Wetzels; Richard J Glassock; Sanjeev Sethi; Fernando C Fervenza
Journal:  Nat Rev Nephrol       Date:  2021-05-20       Impact factor: 28.314

Review 5.  The Role of Cytokines in Nephrotic Syndrome.

Authors:  Elham Ahmadian; Yalda Rahbar Saadat; Elaheh Dalir Abdolahinia; Milad Bastami; Mohammadali M Shoja; Sepideh Zununi Vahed; Mohammadreza Ardalan
Journal:  Mediators Inflamm       Date:  2022-02-09       Impact factor: 4.711

6.  The histopathological spectrum of kidney biopsies in patients with thymoma and myasthenia gravis: a report of 24 biopsies from a single institution.

Authors:  Akira Takahashi; Takamasa Miyauchi; Narihito Tatsumoto; Mercury Y Lin; Jean Hou; Toshiki Doi; Takao Masaki; Michifumi Yamashita
Journal:  Clin Kidney J       Date:  2021-01-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.